Mark E. O’Malley

2.3k total citations
31 papers, 1.8k citations indexed

About

Mark E. O’Malley is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Mark E. O’Malley has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Mark E. O’Malley's work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (10 papers) and Cancer Research and Treatments (4 papers). Mark E. O’Malley is often cited by papers focused on Virus-based gene therapy research (14 papers), CAR-T cell therapy research (10 papers) and Cancer Research and Treatments (4 papers). Mark E. O’Malley collaborates with scholars based in United States, China and United Kingdom. Mark E. O’Malley's co-authors include David L. Bartlett, Steven T. DeKosky, Zong Sheng Guo, Patrick M. Kochanek, James R. Goss, Herbert J. Zeh, Scot Styren, Paweł Kaliński, Donald W. Marion and Padma Sampath and has published in prestigious journals such as Nature Medicine, Journal of Neuroscience and Cancer Research.

In The Last Decade

Mark E. O’Malley

31 papers receiving 1.8k citations

Peers

Countries citing papers authored by Mark E. O’Malley

Since Specialization

Citations

This map shows the geographic impact of Mark E. O’Malley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. O’Malley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. O’Malley more than expected).

Fields of papers citing papers by Mark E. O’Malley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. O’Malley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. O’Malley. The network helps show where Mark E. O’Malley may publish in the future.

Co-authorship network of co-authors of Mark E. O’Malley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. O’Malley. A scholar is included among the top collaborators of Mark E. O’Malley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. O’Malley. Mark E. O’Malley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial 2022 ·Nature Medicine ·Irina Gurevich, Pooja Agarwal, (unknown), (unknown), (unknown), Henry Liu, (unknown), (unknown), Işın Sinem Bağcı, Kunju Sridhar, (unknown), V.K. Yenamandra, Mark E. O’Malley, Marco di Prisco, Sara F. Tufa, Douglas R. Keene, Andrew P. South, Suma Krishnan, M. Peter Marinkovich	99
2	Preclinical Evaluation of a Modified Herpes Simplex Virus Type 1 Vector Encoding Human TGM1 for the Treatment of Autosomal Recessive Congenital Ichthyosis 2020 ·Journal of Investigative Dermatology ·John C. Freedman, Trevor J. Parry, (unknown), Avijit Majumdar, Suma Krishnan, (unknown), Mark E. O’Malley, (unknown), S.D. Yogesha, Sureshkumar Ramasamy, Pooja Agarwal	20
3	Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers 2016 ·Molecular Therapy ·Stephanie Downs‐Canner, Zong Sheng Guo, Roshni Ravindranathan, Caroline J. Breitbach, Mark E. O’Malley, Heather Jones, Anne Moon, J. Andrea McCart, Yongli Shuai, Herbert J. Zeh, David L. Bartlett	112
4	First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity 2014 ·Molecular Therapy ·Herbert J. Zeh, Stephanie Downs‐Canner, J. Andrea McCart, Zong Sheng Guo, Uma N. M. Rao, Lekshmi Ramalingam, Stephen H. Thorne, Heather Jones, Paweł Kaliński, Eva Wieckowski, Mark E. O’Malley, Manijeh Daneshmand, Kang Hu, John C. Bell, (unknown), Anne Moon, Caroline J. Breitbach, David H. Kirn, David L. Bartlett	120
5	A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis 2013 ·Molecular Therapy ·Pragatheeshwar Thirunavukarasu, Magesh Sathaiah, Michael C. Gorry, Mark E. O’Malley, Roshni Ravindranathan, Frances Austin, (unknown), Zong Sheng Guo, David L. Bartlett	24
6	Inhibitors of C5 complement enhance vaccinia virus oncolysis 2013 ·Cancer Gene Therapy ·Deepa Magge, Zong Sheng Guo, Mark E. O’Malley, (unknown), Roshni Ravindranathan, David L. Bartlett	21
7	Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity 2012 ·Neoplasia ·Jun Li, Mark E. O’Malley, Padma Sampath, Paweł Kaliński, David L. Bartlett, Steve H. Thorne	53
8	Mucin as a therapeutic target in pseudomyxoma peritonei 2012 ·Journal of Surgical Oncology ·Haroon A. Choudry, Mark E. O’Malley, Zong Sheng Guo, Herbert J. Zeh, David L. Bartlett	25
9	Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth 2011 ·Molecular Cancer ·Qiang Li, Mark E. O’Malley, David L. Bartlett, Sheng Guo	14
10	Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer 2011 ·Cancer Gene Therapy ·Magesh Sathaiah, (unknown), Mark E. O’Malley, (unknown), Roshni Ravindranathan, Frances Austin, Zong Sheng Guo, David L. Bartlett	10
11	Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer 2011 ·Molecular Therapy ·Jun Li, Mark E. O’Malley, Julie Urban, Padma Sampath, Zong Sheng Guo, Paweł Kaliński, Steve H. Thorne, David L. Bartlett	115
12	Alternate Mechanisms of Initial Pattern Recognition Drive Differential Immune Responses to Related Poxviruses 2010 ·Cell Host & Microbe ·William O’Gorman, Padma Sampath, Erin F. Simonds, Rachel Sikorski, Mark E. O’Malley, Peter O. Krutzik, Hannah Chen, Vijay Panchanathan, Geeta Chaudhri, Gunasegaran Karupiah, David B. Lewis, Steve H. Thorne, Garry P. Nolan	24
13	TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer 2010 ·Gene Therapy ·M. Firdos Ziauddin, Zong Sheng Guo, Mark E. O’Malley, Frances Austin, P. Popovič, (unknown), (unknown), Magesh Sathaiah, Pragatheeshwar Thirunavukarasu, Bingliang Fang, Yong J. Lee, (unknown)	27
14	Three Epigenetic Drugs Up-Regulate Homeobox Gene Rhox5 in Cancer Cells through Overlapping and Distinct Molecular Mechanisms 2009 ·Molecular Pharmacology ·Qiang Li, David L. Bartlett, Michael C. Gorry, Mark E. O’Malley, (unknown)	31
15	A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus 2007 ·Gene Therapy ·Shaolong Yang, Zong Sheng Guo, Mark E. O’Malley, Xiaoyu Yin, Herbert J. Zeh, David L. Bartlett	22
16	Second‐generation tetracycline‐regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness 2004 ·The Journal of Gene Medicine ·Siamak Agha‐Mohammadi, Mark E. O’Malley, (unknown), Zhong Wang, Xiao Xiao, Michael T. Lotze	84
17	Herpes vector–mediated expression of proenkephalin reduces bone cancer pain 2002 ·Annals of Neurology ·James R. Goss, (unknown), Marina Mata, Mark E. O’Malley, William F. Goins, Xiao Hu, Joseph C. Glorioso, David J. Fink	85
18	Interleukm‐1 receptor antagonist suppresses neurotrophin response in injured rat brain 1996 ·Annals of Neurology ·Steven T. DeKosky, Scot Styren, Mark E. O’Malley, James R. Goss, Patrick M. Kochanek, Donald W. Marion, Christopher H. Evans, Paul D. Robbins	84
19	Severe Controlled Cortical Impact in Rats: Assessment of Cerebral Edema, Blood Flow, and Contusion Volume 1995 ·Journal of Neurotrauma ·Patrick M. Kochanek, Donald W. Marion, William Zhang, Joanne K. Schiding, Melissa J. White, Alan M. Palmer, Robert S. B. Clark, Mark E. O’Malley, (unknown), Chien Ho, Steven T. DeKosky	161
20	Photoactivatable Antisense DNA: Suppression of Ampicillin Resistance in Normally Resistant Escherichia coli 1991 ·PubMed ·Francis P. Gasparro, Richard L. Edelson, Mark E. O’Malley, (unknown), (unknown)	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact